Astrazeneca (AZN) Consolidated Net Income (2009 - 2026)
Astrazeneca (AZN) reported Consolidated Net Income of $3.12 billion for Q3 2026, up 22.9% from $2.54 billion a year earlier and up 24.2% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Consolidated Net Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Astrazeneca's Consolidated Net Income came in at $11.03 billion, up 17.3% year-over-year; for FY2025, it came in at $10.23 billion, up 45.3% from FY2024.
- Consolidated Net Income has increased for three consecutive years, with a five-year compound annual growth rate of 26.6% (FY2020 to FY2025).
- By year, Consolidated Net Income came in at $7.04 billion in FY2024 (+18.1%), $5.96 billion in FY2023 (+81.0%), $3.29 billion in FY2022 and $115 million in FY2021 (-96.3%).
- The Q3 2026 figure ranks as the highest quarterly Consolidated Net Income since Q3 2011.
- Year over year, Consolidated Net Income has now increased in each of the last 12 quarters, with growth averaging 35.0% over the last eight quarters.
- The high point for year-over-year Consolidated Net Income in five years was Q2 2023 (growth of 405.6%); the low point was Q1 2022 (a decline of 75.2%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $2.51 billion (Q2 2026), $3.08 billion (Q1 2026) and $2.33 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.12 Bn |
| Jun 30, 2026 | 2.51 Bn |
| Mar 31, 2026 | 3.08 Bn |
| Dec 31, 2025 | 2.33 Bn |
| Sep 30, 2025 | 2.54 Bn |
| Jun 30, 2025 | 2.45 Bn |
| Mar 31, 2025 | 2.92 Bn |
| Dec 31, 2024 | 1.50 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | 1.93 Bn |
| Mar 31, 2024 | 2.18 Bn |
| Dec 31, 2023 | 959.00 Mn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.82 Bn |
| Mar 31, 2023 | 1.80 Bn |
| Dec 31, 2022 | 902.00 Mn |
| Sep 30, 2022 | 1.64 Bn |
| Jun 30, 2022 | 360.00 Mn |
| Mar 31, 2022 | 388.00 Mn |
| Dec 31, 2021 | -346.00 Mn |
API Access
Astrazeneca Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();